diosgenin has been researched along with endothelin-1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, X; Huang, F; Kou, J; Liu, B; Liu, K; Zhao, W | 1 |
1 other study(ies) available for diosgenin and endothelin-1
| Article | Year |
|---|---|
Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cells, Cultured; Diosgenin; Dose-Response Relationship, Drug; Endothelin-1; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Human Umbilical Vein Endothelial Cells; Humans; I-kappa B Kinase; Inflammation Mediators; Insulin Receptor Substrate Proteins; Insulin Resistance; Interleukin-6; Microscopy, Fluorescence; Nitric Oxide; Nitric Oxide Synthase Type III; Palmitic Acid; Phosphorylation; Plasminogen Activator Inhibitor 1; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Salicylic Acid; Signal Transduction; Tumor Necrosis Factor-alpha; Vasodilation | 2012 |